Cargando…
Evaluation of a five-gene signature associated with stromal infiltration for diffuse large B-cell lymphoma
BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is a common non-Hodgkin lymphoma. The development of immunotherapy greatly improves the patient prognosis but there are some exceptions. Thus, screening for better biomarkers for prognostic evaluation could contribute to the treatment of DLBCL patien...
Autores principales: | Nan, Ying-Yu, Zhang, Wen-Jun, Huang, De-Hong, Li, Qi-Ying, Shi, Yang, Yang, Tao, Liang, Xi-Ping, Xiao, Chun-Yan, Guo, Bing-Ling, Xiang, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223837/ https://www.ncbi.nlm.nih.gov/pubmed/34222425 http://dx.doi.org/10.12998/wjcc.v9.i18.4585 |
Ejemplares similares
-
Systemic immune inflammation index, ratio of lymphocytes to monocytes, lactate dehydrogenase and prognosis of diffuse large B-cell lymphoma patients
por: Wu, Xiao-Bo, et al.
Publicado: (2021) -
Onodera's Prognostic Nutritional Index is a novel and useful prognostic marker for gastrointestinal stromal tumors
por: Wang, Hao, et al.
Publicado: (2021) -
Diagnostic and prognostic value of secreted protein acidic and rich in cysteine in the diffuse large B-cell lymphoma
por: Pan, Peng-Ji, et al.
Publicado: (2021) -
Mitophagy-related gene signature predicts prognosis, immune infiltration and chemotherapy sensitivity in colorectal cancer
por: Weng, Jin-Sen, et al.
Publicado: (2023) -
Clinical evaluation of endoscopic resection for treatment of large gastric stromal tumors
por: Xiang, Yuan-Yuan, et al.
Publicado: (2019)